scholarly journals The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Ki-Suk Kim ◽  
Hea Jung Yang ◽  
In-Seung Lee ◽  
Kang-Hoon Kim ◽  
Jiyoung Park ◽  
...  
Keyword(s):  
Enteroendocrine Cells ◽  
Diabetic Mice ◽  
Ginsenoside Rg3 ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Type 2 Diabetic

scholarly journals Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice

PLoS ONE ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. e0181939 ◽  
Author(s):  
Fangfang Xu ◽  
Kevin Yueju Wang ◽  
Nan Wang ◽  
Gangqiang Li ◽  
Dehu Liu
Keyword(s):  
Therapeutic Effect ◽  
Diabetic Mice ◽  
E Coli ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Long Acting ◽  
Type 2 Diabetic

scholarly journals Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients

2001 ◽  
Vol 86 (8) ◽  
pp. 3717-3723 ◽  
Author(s):  
Mai-Britt Toft-Nielsen ◽  
Mette B. Damholt ◽  
Sten Madsbad ◽  
Linda M. Hilsted ◽  
Thomas E. Hughes ◽  
...  
Keyword(s):  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document